158 related articles for article (PubMed ID: 2539388)
1. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.
Rall SC; Newhouse YM; Clarke HR; Weisgraber KH; McCarthy BJ; Mahley RW; Bersot TP
J Clin Invest; 1989 Apr; 83(4):1095-101. PubMed ID: 2539388
[TBL] [Abstract][Full Text] [Related]
2. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW
J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
[TBL] [Abstract][Full Text] [Related]
4. [Apolipoprotein E].
Yamamura T
Nihon Rinsho; 1994 Dec; 52(12):3124-32. PubMed ID: 7853700
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
[TBL] [Abstract][Full Text] [Related]
6. [Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].
Couderc R; Bailleul S
Ann Biol Clin (Paris); 1998; 56(6):651-9. PubMed ID: 9853024
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
[TBL] [Abstract][Full Text] [Related]
8. [Pathology of the human apolipoprotein E gene].
Iron A; Richard P; Beucler I; Thomas G; Pascual de Zulueta M; Bereziat G; Cassaigne A; de Gennes JL
Bull Acad Natl Med; 1994 Mar; 178(3):415-26. PubMed ID: 8076181
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.
Weisgraber KH; Newhouse YM; Taylor JM; Tuan B; Nestruck AC; Davignon J; Mahley RW
Arteriosclerosis; 1989; 9(1):50-7. PubMed ID: 2912421
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of type III hyperlipoproteinemia in Germany.
Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W
Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433
[TBL] [Abstract][Full Text] [Related]
12. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
[TBL] [Abstract][Full Text] [Related]
13. A novel apolipoprotein E5 variant with a 24-bp insertion causing hyperlipidemia.
Yamanouchi Y; Takano T; Hamaguchi H; Tokunaga K
J Hum Genet; 2001; 46(11):633-9. PubMed ID: 11721882
[TBL] [Abstract][Full Text] [Related]
14. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
Hagve TA; Furuset T; Christophersen B; Ose L
Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
[TBL] [Abstract][Full Text] [Related]
15. Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia.
Hsia SH; Connelly PW; Hegele RA
J Investig Med; 1995 Apr; 43(2):187-94. PubMed ID: 7735921
[TBL] [Abstract][Full Text] [Related]
16. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
Feussner G; Dobmeyer J; Nissen H; Hansen TS
Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
[TBL] [Abstract][Full Text] [Related]
17. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
Yamamura T; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Nambu S
J Clin Invest; 1984 Oct; 74(4):1229-37. PubMed ID: 6480826
[TBL] [Abstract][Full Text] [Related]
18. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
[TBL] [Abstract][Full Text] [Related]
19. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
20. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels.
Horita K; Eto M; Saito M; Nakata H; Iwashima Y; Ito H; Takahashi M; Kondo A; Morikawa A; Makino I
Artery; 1993; 20(6):324-36. PubMed ID: 8010888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
